Paradigm Medical Industries IncOver The Counter Market:PDMI
- LAST PRICE0.0002
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0002
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Paradigm Medical Industries Inc | 649.8K | -6.7x | --- |
Tiderock Companies Inc | 1.0M | 0.0x | --- |
Forza Innovations Inc | 252.2K | 0.0x | --- |
Hawkeye Systems Inc | 1.0M | -1.0x | --- |
Nano Mobile Healthcare Inc | 982.1K | 0.0x | --- |
Coded Growth Innovation Center Inc | 1.6K | 0.0x | --- |
Company Information
Paradigm Medical Industries Inc. is engaged in the design, development, manufacture and sale of technology diagnostic eye care instruments and related products for detection of glaucoma and other eye disorders. The Company markets its products to ophthalmologists, optometrists, universities, hospitals and clinics. The Company’s products include A-Scans, A/B Scans, Blood Flow Analyzer, Pachymeter, Field Perimeter, Corneal Topographers, Ocular Electrophysiology, UBMS, Endothelial camera and accessories. The P-2700 is a combination of A-Scan and B-Scan. Paradigm’s Blood Flow Analyzer (BFA) is a tonometer that offers measurement of Ocular Blood flow (OBF). The PARAVUE 300 Corneal Topographer is used in diagnostic and contact lens applications. Paramax provides the detection of glaucoma through its objective 90 second long PERG test. The P60 UBM is the Ultrasound Bio Microscope and provides unprecedented image accuracy. The PARACAM 1000 is a non-contact endothelial microscope.
Contact Information
- Headquarters
- 2355 South 1070 WestSALT LAKE CITY, UT, United States 84119
- Phone
- 801-977-8970
- Fax
- 801-977-8973
Executives
- Chairman of the Board
- Jim Hudak
- President, Treasurer
- Stephen Davis
- Chief Executive Officer, Director
- John Watts
- Director
- Keith Ignotz
- Director
- John Pingree
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $649.8K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 3.2B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -6.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
